Stephen Kennedy Smith
Fondatore presso Pear Therapeutics (US), Inc.
Profilo
Stephen Kennedy Smith is the founder of Pear Therapeutics (US), Inc., where he holds the title of Executive Vice President-Corporate Development.
Pear Therapeutics (US), Inc. was founded in 2013.
He also served as a Director at Med-Design Corp.
In terms of education, Mr. Smith holds graduate degrees from The Trustees of Columbia University in The City of New York, Harvard University, and Harvard Graduate School of Education.
Posizioni attive di Stephen Kennedy Smith
| Società | Posizione | Inizio |
|---|---|---|
Pear Therapeutics (US), Inc.
 Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Fondatore | 12/06/2014 |
Precedenti posizioni note di Stephen Kennedy Smith
| Società | Posizione | Fine |
|---|---|---|
| Med-Design Corp. | Direttore/Membro del Consiglio | 07/06/2006 |
Formazione di Stephen Kennedy Smith
| Harvard University | Graduate Degree |
| The Trustees of Columbia University in The City of New York | Graduate Degree |
| Harvard Graduate School of Education | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
| Med-Design Corp. | Health Technology |
Pear Therapeutics (US), Inc.
Pear Therapeutics (US), Inc. Packaged SoftwareTechnology Services Pear Therapeutics (US), Inc. develops and provides a platform that combines pharmaceutical preparations with scientifically validated software applications. It offers eFormulation, pharmaceutical-software combination products. The firm combines digital therapies with supplements, medical foods and pharmaceuticals to create more effective treatment solutions. The company was founded in 2013 by Corey M. McCann, Stephen Kennedy Smith and William Greene and is headquartered in Boston. MA. | Technology Services |
- Borsa valori
- Insiders
- Stephen Kennedy Smith
